Hakan Postacı1, Baha Zengel2, Ulkem Yararbaş3, Adam Uslu2, Nuket Eliyatkın1, Göksever Akpınar2, Fevzi Cengiz2, Raika Durusoy4. 1. Department of Pathology, Turkish Ministry of Health İzmir Bozyaka Research and Training Hospital, İzmir, Turkey. 2. Department of General Surgery, Turkish Ministry of Health İzmir Bozyaka Research and Training Hospital, İzmir, Turkey. 3. Department of Nuclear Medicine, Ege University Medical Faculty, İzmir, Turkey. 4. Department of Public Health, Ege University Medical Faculty, İzmir, Turkey.
Abstract
BACKGROUND: Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in patients with T1-2N0M0 breast cancers. AIMS: To determine the prognostic significance of primary tumour-related clinico-histopathological factors on axillary and non-sentinel lymph node involvement of patients who underwent sentinel lymph node biopsy. STUDY DESIGN: Retrospective clinical study. METHODS: In the present study, 157 sentinel lymph node biopsies were performed in 151 consecutive patients with early stage breast cancer between June 2008 and December 2011. RESULTS: Successful lymphatic mapping was obtained in 157 of 158 procedures (99.4%). The incidence of larger tumour size (2.543±1.21 vs. 1.974±1.04), lymphatic vessel invasion (70.6% vs. 29.4%), blood vessel invasion (84.2% vs. 15.8%), and invasive lobular carcinoma subtype (72.7% vs. 27.3%) were statistically significantly higher in patients with positive SLNs. Logistic stepwise regression analysis disclosed tumour size (odds ratio: 1.51, p=0.0021) and lymphatic vessel invasion (odds ratio: 4.68, p=0.001) as significant primary tumour-related prognostic determinants of SLN metastasis. CONCLUSION: A close relationship was identified between tumour size and lymphatic vessel invasion of the primary tumour and axillary lymph node involvement. However, the positive predictive value of these two independent variables is low and there is no compelling evidence to recommend their use in routine clinical practice.
BACKGROUND: Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in patients with T1-2N0M0 breast cancers. AIMS: To determine the prognostic significance of primary tumour-related clinico-histopathological factors on axillary and non-sentinel lymph node involvement of patients who underwent sentinel lymph node biopsy. STUDY DESIGN: Retrospective clinical study. METHODS: In the present study, 157 sentinel lymph node biopsies were performed in 151 consecutive patients with early stage breast cancer between June 2008 and December 2011. RESULTS: Successful lymphatic mapping was obtained in 157 of 158 procedures (99.4%). The incidence of larger tumour size (2.543±1.21 vs. 1.974±1.04), lymphatic vessel invasion (70.6% vs. 29.4%), blood vessel invasion (84.2% vs. 15.8%), and invasive lobular carcinoma subtype (72.7% vs. 27.3%) were statistically significantly higher in patients with positive SLNs. Logistic stepwise regression analysis disclosed tumour size (odds ratio: 1.51, p=0.0021) and lymphatic vessel invasion (odds ratio: 4.68, p=0.001) as significant primary tumour-related prognostic determinants of SLN metastasis. CONCLUSION: A close relationship was identified between tumour size and lymphatic vessel invasion of the primary tumour and axillary lymph node involvement. However, the positive predictive value of these two independent variables is low and there is no compelling evidence to recommend their use in routine clinical practice.
Entities:
Keywords:
Breast neoplasms; lymphatic metastasis; sentinel lymph node biopsy
Authors: V Ozmen; H Karanlik; N Cabioglu; A Igci; M Kecer; O Asoglu; S Tuzlali; A Mudun Journal: Breast Cancer Res Treat Date: 2006-01 Impact factor: 4.872
Authors: Liling Zhu; Liang Jin; Shunrong Li; Kai Chen; Weijuan Jia; Quanyuan Shan; Stephen Walter; Erwei Song; Fengxi Su Journal: Breast Cancer Res Treat Date: 2013-01-05 Impact factor: 4.872
Authors: Giovanni D'Eredità; Vito Leopoldo Troilo; Carmela Giardina; Anna Napoli; Giuseppe Rubini; Fernando Fischetti; Tommaso Berardi Journal: Clin Breast Cancer Date: 2010-12-01 Impact factor: 3.225
Authors: M van der Heiden-van der Loo; M Schaapveld; V K Y Ho; S Siesling; E J T Rutgers; P H M Peeters Journal: Ann Oncol Date: 2013-07-17 Impact factor: 32.976
Authors: M B Klevesath; K Pantel; O Agbaje; E Provenzano; G C Wishart; P Gough; S E Pinder; S Duffy; A D Purushotham Journal: Breast Date: 2013-05-29 Impact factor: 4.380
Authors: Savitri Krishnamurthy; Funda Meric-Bernstam; Anthony Lucci; Rosa F Hwang; Henry M Kuerer; Gildy Babiera; Fredrick C Ames; Barry W Feig; Merrick I Ross; Eva Singletary; Kelly K Hunt; Isabelle Bedrosian Journal: Cancer Date: 2009-04-01 Impact factor: 6.860
Authors: Laura S Jiwa; Paul J van Diest; Laurien D Hoefnagel; Jelle Wesseling; Pieter Wesseling; Cathy B Moelans Journal: BMC Cancer Date: 2014-11-22 Impact factor: 4.430